Embla

The company provides a managed weight and cardiometabolic care program that combines behavior-first coaching with a low-dose GLP-1 medication protocol. Their platform uses a structured tapering model to reduce long-term medication reliance and costs while addressing obesity, prediabetes, and metabolic syndrome. The service is primarily marketed to self-funded employers and health plans as a digital-first solution to manage healthcare spend and employee wellbeing.